Pay in 4 interest-free payments of $14.50 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Aticaprant (CERC-501) has a rapid absorption (tmax=1-2 h) and good oral bioavailability (F=25%)
181(2):710-724
N-2-Biphenylyl-7-nitro-2
It is a useful chemical probe to target Skp2
Induction of more physiologically T-cell driven responses such as host vs
LDE225 - Hedgehog Antagonist. CAS# 956697-53-3 size:2mg solid Aticaprant (CERC-501) has a rapidLDE225, CAS No. 956697 53 3, is a potent and specific Hedgehog pathway inhibitor through binding and antagonizing Smo with an IC50 of 11 nM. It is currently in the clinical trials to treat cancers. It inhibited Hh signaling and induces tumor regression in animal models of medulloblastoma. It sensitized chemotherapy resistant ovarian cancer cell lines to paclitaxel, but not to carboplatin. In one of the clinical trials, treatment with 0. 75% LDE225
US$ 110.30
US$ 106.08
US$ 15.00
US$ 38.50
US$ 43.59